Nashat Amir made two open market purchases of Camp4 Therapeutics Corp ($CAMP) shares in the last year, totaling nearly $2 million, with the most recent on September 11, 2025. These buys rank 319th among 4,983 insiders by amount, surpassing the average of $1.46 million across 3.29 transactions per insider. Nashat Amir reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 11, 2025 | Camp4 Therapeutics Corp | $CAMP | Nashat Amir | Not found | P | Common Stock | 1221721 | $1.53 | 3,734,590.0000 | 20,161,072 | 48.62% | 6.06% |
| Sept. 11, 2025 | Camp4 Therapeutics Corp | $CAMP | Nashat Amir | Not found | P | Common Stock | 85468 | $1.53 | 1,106,751.0000 | 20,161,072 | 8.37% | 0.42% |
| June 25, 2025 | Camp4 Therapeutics Corp | $CAMP | Nashat Amir | Director | A | Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 20,161,072 | 9999.99% | 0.04% |
| Oct. 15, 2024 | Camp4 Therapeutics Corp | $CAMP | Nashat Amir | Director | C | Common Stock | 353718 | $0.00 | 1,603,779.0000 | 0 | 28.30% | 0.00% |
| Oct. 15, 2024 | Camp4 Therapeutics Corp | $CAMP | Nashat Amir | Director | C | Common Stock | 24745 | $0.00 | 112,193.0000 | 0 | 28.30% | 0.00% |
| Oct. 15, 2024 | Camp4 Therapeutics Corp | $CAMP | Nashat Amir | Director | P | Common Stock | 909090 | $11.00 | 909,090.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2024 | Camp4 Therapeutics Corp | $CAMP | Nashat Amir | Director | C | Series A Prime Preferred Stock | 14020475 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Camp4 Therapeutics Corp | $CAMP | Nashat Amir | Director | C | Series A Prime Preferred Stock | 980829 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Camp4 Therapeutics Corp | $CAMP | Nashat Amir | Director | C | Series B Preferred Stock | 3967234 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Camp4 Therapeutics Corp | $CAMP | Nashat Amir | Director | C | Series B Preferred Stock | 277536 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Camp4 Therapeutics Corp | $CAMP | Nashat Amir | Director | C | Common Stock | 87448 | $0.00 | 87,448.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2024 | Camp4 Therapeutics Corp | $CAMP | Nashat Amir | Director | C | Common Stock | 1250061 | $0.00 | 1,250,061.0000 | 0 | 9999.99% | 0.00% |
| May 9, 2024 | Scholar Rock Holding Corp | $SRRK | Nashat Amir | Not found | J | Common Stock | 98257 | $0.00 | 38,639.0000 | 95,892,601 | 71.77% | 0.10% |
| May 9, 2024 | Scholar Rock Holding Corp | $SRRK | Nashat Amir | Not found | J | Common Stock | 13096 | $0.00 | 38,602.0000 | 95,892,601 | 51.34% | 0.01% |
| May 9, 2024 | Scholar Rock Holding Corp | $SRRK | Nashat Amir | Not found | J | Common Stock | 27606 | $0.00 | 135,113.0000 | 95,892,601 | 16.97% | 0.03% |
| May 9, 2024 | Scholar Rock Holding Corp | $SRRK | Nashat Amir | Not found | J | Common Stock | 322 | $0.00 | 40,108.0000 | 95,892,601 | 0.81% | 0.00% |
| May 9, 2024 | Scholar Rock Holding Corp | $SRRK | Nashat Amir | Not found | J | Common Stock | 276 | $0.00 | 38,915.0000 | 95,892,601 | 0.71% | 0.00% |
| May 9, 2024 | Scholar Rock Holding Corp | $SRRK | Nashat Amir | Not found | J | Common Stock | 276 | $0.00 | 38,639.0000 | 95,892,601 | 0.71% | 0.00% |
| May 9, 2024 | Scholar Rock Holding Corp | $SRRK | Nashat Amir | Not found | J | Common Stock | 37 | $0.00 | 38,639.0000 | 95,892,601 | 0.10% | 0.00% |
| May 9, 2024 | Scholar Rock Holding Corp | $SRRK | Nashat Amir | Not found | J | Common Stock | 472394 | $0.00 | 1,689,592.0000 | 95,892,601 | 21.85% | 0.49% |
| May 9, 2024 | Scholar Rock Holding Corp | $SRRK | Nashat Amir | Not found | J | Common Stock | 98257 | $0.00 | 136,896.0000 | 95,892,601 | 254.29% | 0.10% |